Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
about
Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A.Pathways for potentiation of immunogenicity during adjuvant-assisted immunizations with Plasmodium falciparum major merozoite surface protein 1.Efficacy of two alternate vaccines based on Plasmodium falciparum merozoite surface protein 1 in an Aotus challenge trial.Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccines.Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.Adjuvant-dependent immune response to malarial transmission-blocking vaccine candidate antigens.New age adjuvants and delivery systems for subunit vaccines.Molecular adjuvants and immunomodulators: new approaches to immunization.Malaria vaccine development.Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environmentRoles of conserved and allelic regions of the major merozoite surface protein (gp195) in immunity against Plasmodium falciparum.Biological activities of anti-merozoite surface protein-1 antibodies induced by adjuvant-assisted immunizations in mice with different immune gene knockouts.
P2860
Q33597356-F9DDF3BC-D058-41A1-9C13-676470585373Q33767686-D8B3FC53-B410-4233-ACB6-10759DF7DDDBQ34006332-D3B183E2-4072-4F2B-9A9A-F815597AEA19Q35010158-F29BD9F9-B770-4223-9B18-EC54E74230BEQ35486529-5510BD6C-64A8-46BA-9D56-1D24FB3F7984Q35504908-A550BA72-4930-4788-9F52-89FBEECDC86DQ35762375-346D7C2C-D5D0-4F67-B877-C78AD4324DEDQ36231958-0430E7F1-8CA0-4901-A1D1-E0614FE574F8Q36265526-B3B31352-7EED-404F-BD79-B0A95138BB9CQ36641572-CE99F50F-7817-4522-81C0-3445E900FD98Q36641624-92E0B38F-D00C-431B-8283-11A350BD8464Q36766169-B54C5312-1B59-4856-8B34-B104195FB745Q36943106-D1AD753F-C801-4DA0-B065-988018D3276CQ39085980-B32BCFEC-8B8C-44D0-9EA8-369CDD1127B9
P2860
Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@en
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@nl
type
label
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@en
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@nl
prefLabel
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@en
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@nl
P2093
P2860
P1476
Synthetic low-toxicity muramyl ...... ozoite surface protein, gp195.
@en
P2093
Kusumoto S
Siddiqui WA
P2860
P304
P407
P577
1991-05-01T00:00:00Z